본문으로 건너뛰기
← 뒤로

Pulmonary intravascular large B-cell lymphoma misdiagnosed as allergic pneumonia: a case report and literature review.

Therapeutic advances in respiratory disease 2026 Vol.20() p. 17534666261424374

Deng H, Guo B, Chen G, Li Q, Feng D, Yang C, Zhong X, Luo Q, Li S, Han Q

📝 환자 설명용 한 줄

Pulmonary intravascular large B-cell lymphoma (PIVLBCL) is an extremely rare subtype of extranodal diffuse large B-cell lymphoma (DLBCL).

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Deng H, Guo B, et al. (2026). Pulmonary intravascular large B-cell lymphoma misdiagnosed as allergic pneumonia: a case report and literature review.. Therapeutic advances in respiratory disease, 20, 17534666261424374. https://doi.org/10.1177/17534666261424374
MLA Deng H, et al.. "Pulmonary intravascular large B-cell lymphoma misdiagnosed as allergic pneumonia: a case report and literature review.." Therapeutic advances in respiratory disease, vol. 20, 2026, pp. 17534666261424374.
PMID 41793148

Abstract

Pulmonary intravascular large B-cell lymphoma (PIVLBCL) is an extremely rare subtype of extranodal diffuse large B-cell lymphoma (DLBCL). This hematologic malignancy exhibits nonspecific radiological features, including ground glass opacities (GGOs), often leading to misdiagnosis as interstitial lung disease (ILD). We present a 51-year-old female hairdresser with progressive dyspnea and 20 years of occupational hair dye exposure. Initially, she was misdiagnosed with chronic bronchitis due to a persistent dry cough. Then her initial chest CT demonstrated diffuse bilateral GGOs with isolated diffusion capacity of the lungs for carbon monoxide (DLCO) reduction (46.1% predicted) and normal spirometry, which led to a second misdiagnosis as hypersensitivity pneumonitis (HP). Despite initial improvement with corticosteroids, respiratory deterioration occurred during tapering. Finally, transbronchial lung cryobiopsy (TBCB) confirmed PIVLBCL, showing intravascular lymphoid proliferation (CD20+/BCL-6+/Ki-67≈80%). The R-CHOP chemotherapy treatment led to a complete remission for her, and the DLCO improved to 68% of the predicted value at the 6-month follow-up. A literature review of 75 PIVLBCL patients revealed that fever (74.7%) and dyspnea (65.3%) were the predominant presentations. GGOs were observed in 54.7% of cases, with frequent misdiagnosis as ILD (31.8%) or pneumonia (31.8%). TBCB provided definitive diagnostic evidence, demonstrating its clinical utility in resolving ambiguous pulmonary opacities. Clinicians should maintain high suspicion for PIVLBCL when encountering diffuse GGOs with isolated DLCO reduction, even without classic risk factors.

MeSH Terms

Humans; Female; Middle Aged; Diagnostic Errors; Lymphoma, Large B-Cell, Diffuse; Alveolitis, Extrinsic Allergic; Antineoplastic Combined Chemotherapy Protocols; Rituximab; Lung Neoplasms; Cyclophosphamide; Doxorubicin; Vincristine; Prednisone; Tomography, X-Ray Computed; Predictive Value of Tests; Vascular Neoplasms; Treatment Outcome; Biopsy

같은 제1저자의 인용 많은 논문 (5)